ipamorelin clinical trials safety trial ipamorelin safety adverse effects clinical trial From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug development Pharmacovigilance safety Mon. in clinical
Description
L.KenslerT
According to the mentioned mechanisms, it is expected that riboflavin deficiency could increase lipid peroxidation
Developmental cell
Available at: Accessed August 3, 2020
